Abbott Panbio Covid-19-Flu A&B Rapid Panel Instructions

October 30, 2023
Abbott

ENABLE TIMELY DIFFERENTIAL
DIAGNOSIS AND TREATMENT
OF COVID-19 AND FLU A&B USING A SINGLE SWAB

Abbott Panbio Covid-19-Flu A&B Rapid Panel

PANBIO™ COVID-19/FLU A&B RAPID PANEL (NASOPHARYNGEAL)

  • For patients presenting symptoms or suspected of current COVID-19, Flu A and/or B infection
  • Only 1 nasopharyngeal swab for both COVID-19 and Flu A&B
  • Simplified workflow with pre-filled buffer tube
  • No instruments needed to interpret results
  • Results in 15 minutes

Panbio ™ is the trusted brand used in more than 100 countries.

DESIGNED FOR EASY TESTING

| | Abbott Panbio Covid-19-Flu A&B Rapid Pane - SIMPLE
T
---|---|---
PRE-FILLED BUFFER TUBE WITH INTEGRATED DROPPER CAP.
NO MANUAL FILLING NEEDED| ONLY ONE SPECIMEN COLLECTING SWAB NEEDED| SIMPLE TEST CASSETTE DESIGN WITH ONE SAMPLE WELL

TEST PROCEDURE

Consult Instructions for Use for complete procedure.

Abbott Panbio Covid-19-Flu A&B Rapid Pane - TEST
PROCEDURESPECIFICATIONS

  • TEST TIME: 15 MINUTES
  • STORAGE: 2°C–30°C
  •  CE MARK
  •  SAMPLE TYPE: Nasopharyngeal (NP) swab

PERFORMANCE

| COVID-19| COVID-19
(Ct≤30)| FLU A| FLU B
---|---|---|---|---
SENSITIVITY| 88.00%| 94.40%| 92.00%|
SPECIFICITY| 100%| 100%| 100%|
95% Cl (Sens.)| 80% – 93.6%| 87.5% – 98.2%| 80.8% – 97.8%
 95% CI (Spec.)| 98.2% – 100%| 98.2% – 100%| 98.2% – 100%

INTENDED USE: The Panbio™ COVID-19/Flu A&B Rapid Panel (NP) is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 and Influenza A&B antigen (Ag) in human nasopharyngeal swab specimens from individuals, who meet COVID-19 and Influenza clinical and/or epidemiological criteria. Panbio™ COVID-19/Flu A&B Rapid Panel (NP) is for professional use and is intended to be used as an aid in the diagnosis of SARS-CoV-2 and Influenza infection. The product may be used in laboratory and non-laboratory environment.
The test provides preliminary test results. Negative results don’t preclude SARS-CoV-2 and Influenza A&B infection and they cannot be used as the sole basis for treatment or other management decisions. Negative results should be combined with  clinical observations, patient history, and epidemiological information.

ORDER INFORMATION

  • Panbio™ COVID-19/Flu A&B Rapid Panel (Nasopharyngeal)
  • CATALOG NUMBER: 62FK10; 10 tests/kit (control kit sold separately; catalog number: 62FK11C)
  • CONTENTS: 10 Test Devices, 10 Extraction Buffer Tubes, 10 Nozzle Caps, 10 Sterilized Nasopharyngeal Swabs For Specimen Collection, 1 Tube Rack, 1 Instructions For Use (IFU) with Quick Reference Guide (QRG)

CONTACT YOUR LOCAL REPRESENTATIVE TODAY.

globalpointofcare.abbott
Product not available in all countries.
© 2022 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners.
COL-12204-01 05/22

Read User Manual Online (PDF format)

Read User Manual Online (PDF format)  >>

Download This Manual (PDF format)

Download this manual  >>

Related Manuals